Open an account

Alpha Tau Medical

DRTSW · NASDAQ

$3.24+$0.13 (+4.18%)TodayMarket closed ·
Prev close $3.11

DRTSW key statistics

Market cap
0
Price-earnings ratio
0.00
Dividend yield
—
Average volume
22.60K
Volume
6.62K
Open price
$3.19
High today
$3.30
Low today
$3.19
52 Week high
$4.62
52 Week low
$0.28

Alpha Tau Medical (DRTSW) at a glance

As of Oct 23, 2026, Alpha Tau Medical (DRTSW) shares are priced at $3.24, giving the company a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the stock has traded between $3.19 and $3.30. The current price is 1.6% above the day's low and 1.8% below its high.

Volume so far is 6.62K shares, below the average of 22.60K shares a day.

Over the past year Alpha Tau Medical has ranged from $0.28 to $4.62, and now sits 68% of the way up that range.

DRTSW news

  • Press releaseGlobe Newswire

    Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions

  • Press releaseGlobe Newswire

    Alpha Tau Announces FDA Approval of IDE Supplement to Expand Alpha DaRT® IMPACT Trial to Patients with Pancreatic Cancer Receiving Gemcitabine with Abraxane® (Nab-Paclitaxel)

  • Press releaseGlobe Newswire

    Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

  • Press releaseGlobe Newswire

    Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.